Lila Sciences
Lila Sciences raises $200M Series A at $800M valuation
Quick Facts
Lila Sciences: Series A Funding Round
Lila Sciences has successfully raised $200M in Series A funding, reaching a valuation of $800M.
Company Overview
Develops AI-powered platform for accelerating therapeutic antibody discovery
Funding Details
The Series A round was led by Foresite Capital, with participation from Perceptive Advisors.
Company Information
- Headquarters: San Francisco, CA
- Founded: 2023
- Employees: 80+
- Category: Biotech
Investment
Lila Sciences plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Foresite Capital: Verified investor in Series A
- Perceptive Advisors: Verified investor in Series A
Key Investors
About the Author
Related Company Reports
Arthrosi Therapeutics raises $153M Series E at $800M valuation
Arthrosi Therapeutics raises $153M in Series E at $800M valuation. Developing next-generation gout treatment drug for chronic conditions...
HorizonStudio Raises $100M Growth to Transform Biotech
HorizonStudio has secured $100M Growth in funding to accelerate growth and innovation. Leading artificial intelligence infrastructure enabling scalable ML deployment for businesses...
StreamData Raises $15M Seed to Transform Biotech
StreamData has secured $15M Seed in funding to accelerate growth and innovation. Leading artificial intelligence infrastructure enabling scalable ML deployment for businesses...
